Redeye: Stillfront - Trimmed growth forecast, increased EBITDAC
Redeye updates on Stillfront following the company’s Q2-results where revenue was close to our expectations while EBITDAC was stronger than expected. The growth outlook remains uncertain, and we have trimmed our growth forecast somewhat, however, EBITDAC estimates are slightly increased on the back of stronger profitability and lower capital development costs.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/